Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05028426
Other study ID # 2018/P01/266
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2015
Est. completion date October 2019

Study information

Verified date July 2022
Source Groupe Hospitalier de la Rochelle Ré Aunis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objectives are to describe the transition from traditional care to an enhanced recovery program for the management of total knee arthroplasty, and to evaluate the effect on patient outcomes.


Description:

Enhanced recovery programs are an organizational evolution in surgical patient management, in which the patient becomes an actor of his or her own recovery. This multimodal approach aims at optimizing patient physiological and psychological states across preoperative, intraoperative and postoperative domains of care. At la Rochelle hospital, the decision to take the step happened at the end of 2016. It was proposed by a young surgeon that have been trained on this new approach during his studies and who convinced the head of the surgery department of the benefits for the patients, the healthcare workers, and the institution. The transition took place in two stages, first operative and postoperative techniques were modified, and then preoperative education and counselling were added.


Recruitment information / eligibility

Status Completed
Enrollment 455
Est. completion date October 2019
Est. primary completion date December 2018
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients operated on for posterior-stabilized total knee arthroplasty between January 2015 and December 2018 - unilateral arthroplasty - a known address for mailing the study information letter Exclusion Criteria: - revision arthroplasty - patients who refused to the use of their data

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Enhanced recovery program
Enhanced recovery programs are a multimodal approach to optimize patients' physiological and psychological states in the preoperative, intraoperative and postoperative care domains.

Locations

Country Name City State
France Groupe Hospitalier la Rochelle Ré Aunis La Rochelle

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier de la Rochelle Ré Aunis

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients With Early Complication Recorded complications were Bleeding, Deep periprosthetic joint infection, Implant fracture, Instability, Patellofemoral dislocation, Readmission, Reoperation, Revision, Stiffness, Thromboembolic disease, Tibiofemoral dislocation, Vascular injury, Wound complication. 3 months after surgery
Secondary Number of Patients With Late Complication Recorded complications were Bleeding, Deep periprosthetic joint infection, Implant fracture, Instability, Patellofemoral dislocation, Readmission, Reoperation, Revision, Stiffness, Thromboembolic disease, Tibiofemoral dislocation, Vascular injury, Wound complication. up to 28 months after surgery
Secondary Length of Hospital Stay the time between admission for an operation and discharge from the hospital up to 1 month after surgery
Secondary Preoperative Knee Extension Measure in degree of how much the knee straightens during consultation with surgeon up to 1 month before surgery
Secondary Postoperative Knee Extension Measure in degree of how much the knee straightens during consultation with surgeon At 3 months after surgery
Secondary Preoperative Knee Flexion Measure in degree of how much the knee bends during consultation with surgeon up to 1 month before surgery
Secondary Postoperative Knee Flexion Measure in degree of how much the knee bends during consultation with surgeon At 3 months after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05181566 - Metal Ion Levels in Total Hip Arthroplasty (THA) With Modular Dual Mobility Cup Compared to Conventional THA N/A
Completed NCT04490304 - The Analysis of Posterior Soft Tissue Repair Durability N/A
Recruiting NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT04565093 - Efficacy of iPACK After Unilateral TKA N/A
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Recruiting NCT03306810 - Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service N/A
Completed NCT04289025 - Modelling and AI Using Sensor Data to Personalise REHABilitation Following Joint Replacement N/A
Not yet recruiting NCT05014932 - Evaluation of Noise Induced by Ceramic-ceramic Friction Torques of Total Hip Prostheses With Customized Femoral Stem
Active, not recruiting NCT04437888 - Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty Early Phase 1
Completed NCT05420194 - Assessment of Postural Stability in Patients With Total Knee Arthroplasty
Completed NCT03269760 - Multimodal Sleep Pathway for Shoulder Arthroplasty Phase 1
Completed NCT03289247 - Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty N/A
Completed NCT04433962 - Investigation of the Effects of Balance Training on Balance and Functional Status Patients With Total Hip Arthroplasty N/A
Recruiting NCT06025448 - Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? N/A
Recruiting NCT05459259 - Physiotherapy for Arthrofibrosis Following Knee Replacement.
Not yet recruiting NCT05736666 - Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement N/A
Active, not recruiting NCT03692364 - Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Total Hip Arthroplasty N/A
Completed NCT05013879 - Kinesiotape for Edema After Bilateral Total Knee Arthroplasty N/A
Completed NCT04120324 - Incidence of 30 Day Return to Hospital Following Same Day Discharge Total Hip Arthroplasty
Not yet recruiting NCT05509946 - Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA Phase 2/Phase 3